Counting the cost of caplacizumab

被引：19

作者：

Chaturvedi, Shruti ^{[1
]}

机构：

[1] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA

来源：

BLOOD | 2021年 / 137卷 / 07期

关键词：

DEATH;

D O I：

10.1182/blood.2020009250

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

In this issue of Blood, Goshua et al present a timely cost-effectiveness analysis of caplacizumab for immune thrombotic thrombocytopenic purpura (iTTP) and conclude that adding caplacizumab to standard-of-care (SOC) therapy with plasma exchange and immunosuppression is not cost-effective based on outcomes including duration of hospitalization and iTTP recurrence.(1)

引用

页码：871 / 872

页数：2

共 10 条

[1] Development and validation of a predictive model for death in acquired severe ADAMTS13 deficiency-associated idiopathic thrombotic thrombocytopenic purpura: the French TMA Reference Center experience [J].

Benhamou, Ygal ;

Assie, Cyrielle ;

Boelle, Pierre-Yves ;

Buffet, Marc ;

Grillberger, Rana ;

Malot, Sandrine ;

Wynckel, Alain ;

Presne, Claire ;

Choukroun, Gabriel ;

Poullin, Pascale ;

Provot, Francois ;

Gruson, Didier ;

Hamidou, Mohamed ;

Bordessoule, Dominique ;

Pourrat, Jacques ;

Mira, Jean-Paul ;

Le Guern, Veronique ;

Pouteil-Noble, Claire ;

Daubin, Cedric ;

Vanhille, Philippe ;

Rondeau, Eric ;

Palcoux, Jean-Bernard ;

Mousson, Christiane ;

Vigneau, Cecile ;

Bonmarchand, Guy ;

Guidet, Bertrand ;

Galicier, Lionel ;

Azoulay, Elie ;

Rottensteiner, Hanspeter ;

Veyradier, Agnes ;

Coppo, Paul .

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (08) :1181-1186

[2] TTP: long-term outcomes following recovery [J].

George, James N. .

HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2018, :548-552

[3] Cost effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura [J].

Goshua, George ;

Sinha, Pranay ;

Hendrickson, Jeanne E. ;

Tormey, Christopher ;

Bendapudi, Pavan K. ;

Lee, Alfred Ian .

BLOOD, 2021, 137 (07) :969-976

[4] How targeted therapy disrupts the treatment paradigm for acquired TTP: the risks, benefits, and unknowns [J].

Mazepa, Marshall A. ;

Masias, Camila ;

Chaturvedi, Shruti .

BLOOD, 2019, 134 (05) :415-420

[5] Caplacizumab reduces the frequency of major thromboembolic events, exacerbations and death in patients with acquired thrombotic thrombocytopenic purpura [J].

Peyvandi, F. ;

Scully, M. ;

Hovinga, J. A. Kremer ;

Knoebl, P. ;

Cataland, S. ;

De Beuf, K. ;

Callewaert, F. ;

De Winter, H. ;

Zeldin, R. K. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2017, 15 (07) :1448-1452

[6] Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura [J].

Scully, M. ;

Cataland, S. R. ;

Peyvandi, F. ;

Coppo, P. ;

Knobl, P. ;

Hovinga, J. A. Kremer ;

Metjian, A. ;

de la Rubia, J. ;

Pavenski, K. ;

Callewaert, F. ;

Biswas, D. ;

De Winter, H. ;

Zeldin, R. K. .

NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (04) :335-346

[7] The high cost of prescription drugs: causes and solutions [J].

Vincent Rajkumar, S. .

BLOOD CANCER JOURNAL, 2020, 10 (06)

[8] ADAMTS13 and VWF activities guide individualized caplacizumab treatment in patients with aTTP [J].

Voelker, Linus A. ;

Kaufeld, Jessica ;

Miesbach, Wolfgang ;

Braehler, Sebastian ;

Reinhardt, Martin ;

Kuehne, Lucas ;

Muehlfeld, Anja ;

Schreiber, Adrian ;

Gaedeke, Jens ;

Toelle, Markus ;

Jabs, Wolfram J. ;

Ozcan, Fedai ;

Markau, Silke ;

Girndt, Matthias ;

Bauer, Frederic ;

Westhoff, Timm H. ;

Felten, Helmut ;

Hausberg, Martin ;

Brand, Marcus ;

Gerth, Jens ;

Bieringer, Markus ;

Bommer, Martin ;

Zschiedrich, Stefan ;

Schneider, Johanna ;

Elitok, Saban ;

Gawlik, Alexander ;

Gaeckler, Anja ;

Kribben, Andreas ;

Schwenger, Vedat ;

Schoenermarck, Ulf ;

Roeder, Maximilian ;

Radermacher, Joerg ;

Bramstedt, Joern ;

Morgner, Anke ;

Herbst, Regina ;

Harth, Ana ;

Potthoff, Sebastian A. ;

von Auer, Charis ;

Wendt, Ralph ;

Christ, Hildegard ;

Brinkkoetter, Paul T. ;

Menne, Jan .

BLOOD ADVANCES, 2020, 4 (13) :3093-3101

[9]

Ways and Means Committee, PAINF PILL SWALL US

[10] ISTH guidelines for treatment of thrombotic thrombocytopenic purpura [J].

Zheng, X. Long ;

Vesely, Sara K. ;

Cataland, Spero R. ;

Coppo, Paul ;

Geldziler, Brian ;

Iorio, Alfonso ;

Matsumoto, Masanori ;

Mustafa, Reem A. ;

Pai, Menaka ;

Rock, Gail ;

Russell, Lene ;

Tarawneh, Rawan ;

Valdes, Julie ;

Peyvandi, Flora .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2020, 18 (10) :2496-2502

← 1 →